Surgery Partners (SGRY) Reiterated at Buy by Benchmark as Guidance Maintained

August 11, 2026 8:01 AM

Benchmark analyst Bill Sutherland reiterated a Buy rating and $24.00 price target on Surgery Partners (NASDAQ: SGRY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found